Go Pro

Sei Investments Co. Has $1.63 Million Position in Heartflow, Inc. $HTFL

Heartflow logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Sei Investments increased its Heartflow stake by 342.5% in the first quarter, ending with 67,048 shares valued at approximately $1.63 million. Several other institutional investors also initiated positions.
  • Analyst sentiment is broadly positive, with a consensus “Moderate Buy” rating and an average price target of $36.57, compared with Heartflow’s opening price of $29.35.
  • Heartflow reported quarterly revenue of $52.59 million, up 41.3% year over year, and posted an EPS loss of $0.16 that beat estimates. However, insiders sold 93,243 shares worth about $2.89 million over the past three months.
  • MarketBeat previews top five stocks to own in September.

Sei Investments Co. grew its holdings in Heartflow, Inc. (NASDAQ:HTFL - Free Report) by 342.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 67,048 shares of the company's stock after buying an additional 51,895 shares during the quarter. Sei Investments Co. owned approximately 0.08% of Heartflow worth $1,631,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Caitong International Asset Management Co. Ltd bought a new position in shares of Heartflow in the fourth quarter worth about $27,000. Russell Investments Group Ltd. acquired a new stake in shares of Heartflow in the fourth quarter valued at approximately $45,000. Legal & General Group Plc bought a new position in Heartflow in the 3rd quarter worth approximately $59,000. Strs Ohio bought a new position in Heartflow in the 4th quarter worth approximately $99,000. Finally, Police & Firemen s Retirement System of New Jersey acquired a new position in Heartflow during the 4th quarter worth $131,000.

Wall Street Analyst Weigh In

Several research firms have recently commented on HTFL. Robert W. Baird began coverage on Heartflow in a research note on Friday, July 31st. They issued an "outperform" rating and a $34.00 target price for the company. Wells Fargo & Company upped their price target on Heartflow from $35.00 to $37.00 and gave the company an "overweight" rating in a research note on Friday, May 15th. Piper Sandler reissued an "overweight" rating on shares of Heartflow in a report on Thursday, June 11th. Freedom Capital upgraded shares of Heartflow to a "strong-buy" rating in a research report on Tuesday, June 30th. Finally, Weiss Ratings upgraded shares of Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $36.57.

Get Our Latest Research Report on Heartflow

Heartflow Trading Up 1.8%

HTFL stock opened at $29.35 on Tuesday. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $41.22. The firm has a market cap of $2.53 billion and a PE ratio of -9.44. The business's 50-day moving average price is $28.74 and its two-hundred day moving average price is $27.76.

Heartflow (NASDAQ:HTFL - Get Free Report) last announced its quarterly earnings results on Thursday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.08. The business had revenue of $52.59 million during the quarter. The firm's quarterly revenue was up 41.3% compared to the same quarter last year. On average, analysts forecast that Heartflow, Inc. will post -0.82 earnings per share for the current year.

Insider Buying and Selling

In other Heartflow news, insider Campbell Rogers sold 9,219 shares of the stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $28.34, for a total transaction of $261,266.46. Following the completion of the transaction, the insider owned 78,731 shares in the company, valued at approximately $2,231,236.54. This represents a 10.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 22,562 shares of Heartflow stock in a transaction dated Friday, July 10th. The shares were sold at an average price of $27.75, for a total value of $626,095.50. Following the completion of the sale, the chief executive officer directly owned 435,373 shares in the company, valued at $12,081,600.75. This represents a 4.93% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 93,243 shares of company stock valued at $2,891,879. 7.70% of the stock is owned by company insiders.

Heartflow Profile

(Free Report)

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

Recommended Stories

Institutional Ownership by Quarter for Heartflow (NASDAQ:HTFL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Heartflow Right Now?

Before you consider Heartflow, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Heartflow wasn't on the list.

While Heartflow currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines